Key Points
- Astera Labs General Counsel Philip Mazzara sold 10,000 shares on April 1 at an average price of $107.77 for about $1,077,700, and the transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
- The sale reduced Mazzara's holdings by 7.81% to 118,084 shares (valued at roughly $12.73M) and follows prior insider sales this year (10,000 shares on Mar 2 and 4,849 shares on Feb 17), signaling a pattern of dispositions.
- Astera Labs recently reported strong results (Q4 revenue +91.8% YoY and a Q1 2026 EPS guide of $0.530–0.540) but trades at a high valuation (market cap ≈ $20B, P/E ≈ 96) amid mixed analyst views (consensus “Moderate Buy,” average target ≈ $199).
Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) General Counsel Philip Mazzara sold 10,000 shares of the stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $107.77, for a total transaction of $1,077,700.00. Following the completion of the transaction, the general counsel directly owned 118,084 shares of the company's stock, valued at $12,725,912.68. The trade was a 7.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Philip Mazzara also recently made the following trade(s):
- On Monday, March 2nd, Philip Mazzara sold 10,000 shares of Astera Labs stock. The stock was sold at an average price of $117.47, for a total transaction of $1,174,700.00.
- On Tuesday, February 17th, Philip Mazzara sold 4,849 shares of Astera Labs stock. The stock was sold at an average price of $123.80, for a total transaction of $600,306.20.
Astera Labs Stock Performance
ALAB stock opened at $117.14 on Friday. The firm has a market cap of $20.06 billion, a PE ratio of 96.02, a P/E/G ratio of 2.31 and a beta of 1.78. The firm's fifty day moving average is $131.56 and its 200 day moving average is $159.64. Astera Labs, Inc. has a one year low of $47.13 and a one year high of $262.90.
Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, topping analysts' consensus estimates of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The business had revenue of $270.58 million during the quarter, compared to the consensus estimate of $249.46 million. During the same quarter in the prior year, the firm posted $0.37 earnings per share. The company's revenue was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Research analysts predict that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.
Analysts Set New Price Targets
Several research analysts have recently weighed in on ALAB shares. Weiss Ratings downgraded Astera Labs from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Monday, February 23rd. Citigroup initiated coverage on shares of Astera Labs in a report on Thursday. They issued a "buy" rating and a $200.00 price target for the company. Barclays set a $165.00 price objective on shares of Astera Labs in a research report on Thursday, January 15th. Loop Capital began coverage on shares of Astera Labs in a research report on Thursday, March 5th. They issued a "buy" rating and a $250.00 target price on the stock. Finally, Royal Bank Of Canada began coverage on shares of Astera Labs in a research note on Wednesday, January 14th. They issued an "outperform" rating and a $225.00 price target on the stock. Fifteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $199.44.
View Our Latest Analysis on ALAB
Institutional Investors Weigh In On Astera Labs
A number of large investors have recently modified their holdings of ALAB. Assetmark Inc. lifted its stake in shares of Astera Labs by 374.1% in the third quarter. Assetmark Inc. now owns 128 shares of the company's stock worth $25,000 after buying an additional 101 shares in the last quarter. Reflection Asset Management purchased a new stake in Astera Labs during the 4th quarter valued at about $25,000. Smartleaf Asset Management LLC raised its holdings in Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company's stock valued at $32,000 after acquiring an additional 152 shares during the last quarter. Hilltop National Bank raised its holdings in Astera Labs by 100.0% in the 4th quarter. Hilltop National Bank now owns 200 shares of the company's stock valued at $33,000 after acquiring an additional 100 shares during the last quarter. Finally, Aventura Private Wealth LLC purchased a new position in Astera Labs in the 4th quarter worth approximately $33,000. Hedge funds and other institutional investors own 60.47% of the company's stock.
Trending Headlines about Astera Labs
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Citi initiated/maintained a Buy and set a $200 price target on ALAB, highlighting PCIe and AI-infrastructure opportunity — a sizable analyst endorsement that can lift sentiment and buying interest. Benzinga Coverage
- Positive Sentiment: Research notes (TipRanks summary) underscore Astera Labs’ PCIe switch leadership and positioning in rack-scale AI connectivity, framing multiyear revenue upside tied to data-center AI buildouts. Astera Labs: Leveraging PCIe Switch Leadership...
- Positive Sentiment: Astera appears on roundups of leading growth stocks with notable insider ownership — a signal some investors use to judge management alignment and conviction, which can support valuation multiple expansion if execution continues. April 2026's Leading Growth Stocks With Insider Ownership
- Neutral Sentiment: Company announced it will report Q1 2026 results after market close on May 5 and hold a conference call — an imminent catalyst that could swing the stock depending on revenue, margins and guidance. Astera Labs Announces Conference Call...
- Negative Sentiment: Recent articles flag a ~36% YTD decline and call out margin pressure and intensifying competition as key near-term risks; these concerns help explain the share-price pullback despite top-line AI/PCIe tailwinds. Should You Hold on to Astera Labs Stock Despite Its 36% Dip in YTD?
- Negative Sentiment: Analyst commentary and newsletter pieces emphasize margin compression risks even as demand grows — if margins miss or competition accelerates, upside expectations tied to AI/PCIe could be delayed. Should You Hold on to Astera Labs Stock Despite Its 36% Dip in YTD? (Zacks)
Astera Labs Company Profile
(
Get Free Report)
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
